The appropriate surgical management of moderate ischemic mitral regurgitation (MR)
at the time of coronary artery bypass graft surgery (CABG) remains controversial.
A recent study demonstrated no beneficial effect to add mitral repair on CABG for
patients with moderate ischemic MR in terms of survival. The possible reason is that
the reverse remodeling resulted in improved mitral valve geometry, increased mitral
closing force and substantial reduction of MR without surgical mitral repair. Therefore,
preoperative prediction of reverse remodeling would be crucial for decision making
for adding MR repair on CABG. A 60-year-old man with ischemic cardiomyopathy was admitted
to our hospital by exacerbation of heart failure symptom. Left ventricular dilatation
(LVEDV: 190 mL), severe impairment of LV systolic function (LVEF: 14.7%) and moderate
MR due to tethering were noted on transthoracic echocardiography. On X-ray coronary
angiography, triple vessel disease was demonstrated. On LGE MRI, subendocardial infarction
with transmural extent of approximately 50% was revealed in inferior-posterior-lateral
wall. We assumed that the reverse remodeling could be expected because amount of scar
was not extensive. After performing CABG and cardiac resynchronization therapy, LV
volume was substantially decreased and moderate MR was disappeared without surgical
mitral repair. This case report suggested the possible utility of preoperative viability
assessment using LGE MRI for the prediction of postoperative reverse remodeling and
improvement of ischemic MR.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Cardiac FailureAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect